108 related articles for article (PubMed ID: 20919820)
1. Long-term cardiovascular risk following platinum-based chemotherapy for germ cell tumors.
Evans C; Williams M; Mazhar D
Future Oncol; 2010 Sep; 6(9):1365-8. PubMed ID: 20919820
[No Abstract] [Full Text] [Related]
2. Cardiovascular events in survivors of high-dose chemotherapy for germ cell tumors.
Ishioka J; Fujii Y; Kageyama Y; Fukuda H; Higashi Y; Kihara K
Int J Urol; 2008 Jul; 15(7):642-5. PubMed ID: 18643784
[TBL] [Abstract][Full Text] [Related]
3. [Platinum antitumor complexes].
Bonetti A; Giuliani J; Muggia F
Recenti Prog Med; 2015 Dec; 106(12):618-28. PubMed ID: 26780071
[TBL] [Abstract][Full Text] [Related]
4. [Cisplatin or carboplatin, that is the question].
Moncharmont C; Auberdiac P; Mélis A; Afqir S; Pacaut C; Chargari C; Merrouche Y; Magné N
Bull Cancer; 2011 Feb; 98(2):164-75. PubMed ID: 21382796
[TBL] [Abstract][Full Text] [Related]
5. Management of good risk germ-cell tumours.
Troost MM; Sternberg CN; de Wit R
BJU Int; 2009 Nov; 104(9 Pt B):1387-91. PubMed ID: 19840018
[TBL] [Abstract][Full Text] [Related]
6. Late cardiovascular toxicity following chemotherapy for germ cell tumors.
Feldman DR; Schaffer WL; Steingart RM
J Natl Compr Canc Netw; 2012 Apr; 10(4):537-44. PubMed ID: 22491050
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of late cardiovascular toxicity from cancer chemotherapy.
Steingart R
J Clin Oncol; 2005 Dec; 23(36):9051-2. PubMed ID: 16301591
[No Abstract] [Full Text] [Related]
8. Long-term survivors of ovarian malignancies after cisplatin-based chemotherapy; cardiovascular risk factors and signs of vascular damage.
de Vos FY; Nuver J; Willemse PH; van der Zee AG; Messerschmidt J; Burgerhof JG; de Vries EG; Gietema JA
Eur J Cancer; 2004 Mar; 40(5):696-700. PubMed ID: 15010070
[TBL] [Abstract][Full Text] [Related]
9. Long-term toxicity of cisplatin in germ-cell tumor survivors.
Chovanec M; Abu Zaid M; Hanna N; El-Kouri N; Einhorn LH; Albany C
Ann Oncol; 2017 Nov; 28(11):2670-2679. PubMed ID: 29045502
[TBL] [Abstract][Full Text] [Related]
10. Cerebrovascular accident during cisplatin-based combination chemotherapy of testicular germ cell tumor: an unusual case report.
Azak A; Oksüzoğlu B; Deren T; Oneç BM; Zengin N
Anticancer Drugs; 2008 Jan; 19(1):97-8. PubMed ID: 18043135
[TBL] [Abstract][Full Text] [Related]
11. Brachial plexus injury during anaesthesia in patients receiving cisplatin-based chemotherapy.
Marzetti G; Marret E; Lotz JP; Gattegno B; Bonnet F
Eur J Anaesthesiol; 2006 Mar; 23(3):262-5. PubMed ID: 16430800
[No Abstract] [Full Text] [Related]
12. Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group Study.
Gershenson DM; Miller AM; Champion VL; Monahan PO; Zhao Q; Cella D; Williams SD;
J Clin Oncol; 2007 Jul; 25(19):2792-7. PubMed ID: 17602084
[TBL] [Abstract][Full Text] [Related]
13. [Current status of chemotherapy of germ cell tumors].
Dieckmann KP; Kreuser ED
Urologe A; 1991 Jan; 30(1):45-55. PubMed ID: 1849674
[TBL] [Abstract][Full Text] [Related]
14. Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors.
Skinner R; Parry A; Price L; Cole M; Craft AW; Pearson AD
Eur J Cancer; 2009 Dec; 45(18):3213-9. PubMed ID: 19850470
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of carboplatin in patients with advanced germ cell tumors refractory to cisplatin.
Motzer RJ; Bosl GJ; Tauer K; Golbey R
Cancer Treat Rep; 1987 Feb; 71(2):197-8. PubMed ID: 3026627
[TBL] [Abstract][Full Text] [Related]
16. Adverse effects of cytotoxics-platinum agents.
Selvaratnam G; Philips RH; Mohamed AK; Radzi A
Adverse Drug React Toxicol Rev; 1997 Aug; 16(3):171-97. PubMed ID: 9512763
[No Abstract] [Full Text] [Related]
17. Risk of leukemia after platinum-based chemotherapy for ovarian cancer.
Travis LB; Holowaty EJ; Bergfeldt K; Lynch CF; Kohler BA; Wiklund T; Curtis RE; Hall P; Andersson M; Pukkala E; Sturgeon J; Stovall M
N Engl J Med; 1999 Feb; 340(5):351-7. PubMed ID: 9929525
[TBL] [Abstract][Full Text] [Related]
18. Is it time to discontinue using high-dose chemotherapy for salvage of patients with advanced germ-cell tumors failing first-line platinum chemotherapy?
Oyan B; Koc Y
Ann Oncol; 2006 Feb; 17(2):349-50. PubMed ID: 16166174
[No Abstract] [Full Text] [Related]
19. Cardiotoxicity: cisplatin and long-term cancer survivors.
Patanè S
Int J Cardiol; 2014 Jul; 175(1):201-2. PubMed ID: 24820740
[No Abstract] [Full Text] [Related]
20. The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface area.
Piketty AC; Fléchon A; Laplanche A; Nouyrigat E; Droz JP; Théodore C; Fizazi K
Br J Cancer; 2005 Oct; 93(8):909-14. PubMed ID: 16205699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
